东方中科(002819) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was ¥615,049,298.14, a decrease of 5.89% compared to ¥653,527,795.80 in the same period last year[5] - The net loss attributable to shareholders was ¥34,577,090.76, representing a 21.97% increase in loss from ¥28,348,354.50 year-on-year[5] - The net cash flow from operating activities was negative at ¥175,077,346.95, a decline of 41.73% compared to the previous year's negative cash flow of ¥123,527,491.71[5] - The basic earnings per share decreased by 22.47% to -¥0.1161 from -¥0.0948 in the same period last year[5] - Net profit for the current period was -¥48,875,786.33, compared to -¥40,977,760.17 in the previous period, indicating a decline of 19.0%[19] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,551,917,855.66, down 0.98% from ¥4,596,836,873.31 at the end of the previous year[5] - Current assets totaled RMB 3,797,197,739.18, down from RMB 3,822,224,926.02 at the start of the period, indicating a decrease of approximately 0.66%[15] - The total liabilities amounted to RMB 1,392,638,960.14, slightly up from RMB 1,389,082,895.91, indicating a marginal increase of about 0.18%[16] - The company's equity increased to RMB 2,839,746,611.34 from RMB 2,839,355,406.89, reflecting a growth of approximately 0.14%[16] - Total assets and equity decreased to ¥4,551,917,855.66 and ¥3,159,278,895.52 respectively, down from ¥4,596,836,873.31 and ¥3,207,753,977.40 in the previous period[17] Cash Flow - The company reported a net cash outflow from operating activities of -¥175,077,346.95, worsening from -¥123,527,491.71 in the previous period[21] - Cash inflow from investment activities was ¥689,154,594.22, significantly higher than ¥111,350,544.11 in the previous period[21] - The net cash inflow from financing activities was $22,779,283.57, compared to $29,282,025.23 in the previous period, indicating a decrease of approximately 22%[22] - The total cash and cash equivalents at the end of the period amounted to $309,488,829.87, down from $688,403,528.84, reflecting a decline of about 55%[22] - The cash outflow from financing activities totaled $190,621,420.88, an increase from $162,095,092.16, representing an increase of approximately 18%[22] Income and Expenditures - The company received government subsidies amounting to ¥8,282,120.28 during the reporting period, contributing to an increase in other income by 211.91%[6][9] - The investment income increased by 327.35% to ¥3,190,695.42, primarily due to higher returns from financial products[9] - The company reported an increase in other income to ¥11,382,338.98 from ¥3,649,270.36, indicating improved performance in this area[18] - The company incurred research and development expenses of ¥54,939,348.62, an increase of 8.4% from ¥50,802,986.01 in the previous period[18] - Total operating costs decreased to ¥677,962,190.34 from ¥695,403,158.84, reflecting a reduction of 2.0%[18] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 28,387[11] - The company repurchased a total of 3,247,000 shares, representing 1.08% of the total issued share capital[12] Legal and Regulatory Matters - The company is currently involved in arbitration regarding performance commitments related to the acquisition of a 78.33% stake in Beijing Wanlihong Technology Co., which may impact future financial performance[13] - The company has reported a judicial freeze on shares held by a major shareholder, which could affect the execution of performance compensation commitments[13] - The company is actively pursuing legal measures to protect its interests and those of its shareholders in the ongoing arbitration case[13] Accounting and Reporting - The company did not undergo an audit for the first quarter report, which may affect the reliability of the financial data presented[23] - The company plans to implement new accounting standards starting in 2025, which may impact future financial reporting[24]